Page 1 of Clinical Trials for EGFR Non-small cell lung cancer, 286 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
Study to Evaluate Safety, Pharmacokinetics, and Preliminary Efficacy of CO-1686 in Previously Treated Mutant Epidermal Growth Factor Receptor (EGFR) Non-Small Cell Lung Cancer (NSCLC)
Last Updated: March 19, 2012
Condition(s): Locally Advanced or Metastatic Non-small Cell Lung Cancer.
2
Completed
Iressa as a First-Line Treatment in Chemonaive Patients With Inoperable Non-Small Cell Lung Cancer
Last Updated: July 27, 2007
Condition(s): Non-Small Cell Lung Cancer
3
Active, not recruiting
PharmacoEconomic Assessment IRESSA® in the Treatment of Non-Small-Cell Lung Cancer (NSCLC)
Last Updated: May 18, 2009
Condition(s): Non-Small Cell Lung Cancer
4
Recruiting
A Non-interventional Study (NIS) Registry for the Epidemiological and Scientific Evaluation of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC) (Stage IIIB/IV Non-small Cell Lung Cancer).
Last Updated: March 16, 2012
Condition(s): Non Small Cell Lung Cancer
5
Recruiting
Treatment With BIBW 2992, Irreversible Inhibitor of EGFR and HER-2 in Non Small Cell Lung Cancer
Last Updated: February 24, 2012
Condition(s): Non-Small Cell Lung Cancer; EGFR Tyrosine Kinase Inhibitor 324674
6
Not yet recruiting
Erlotinib With or Without Bevacizumab in Treating Patients With Stage IV Non-Small Cell Lung Cancer With EGFR Mutations
Last Updated: February 9, 2012
Condition(s): Stage IV Non-small Cell Lung Cancer
7
Completed
Epidemiological Study to Evaluate the Prevalence of Epidermal Growth Factor Receptor (EGFR) Mutation Status in Patients With Newly Diagnosed Locally Advanced or Metastatic Non Small Cell Lung Cancer (NSCLC)
Last Updated: March 15, 2011
Condition(s): Non Small Cell Lung Cancer
8
Recruiting
First-Line EGFR-1 Tyrosine Kinase Inhibition in Patients With NSCLC With Mutant EGFR Gene
Last Updated: June 19, 2006
Condition(s): Lung Neoplasms; Non-Small Cell Lung Cancer; Adenocarcinoma, Bronchiolo-Alveolar
9
Active, not recruiting
High Dose Gefitinib for the Treatment of Carcinomatous Meningitis in Adult Patients With Non-Small Cell Lung Cancer and Known or Suspected EGFR Mutations
Last Updated: November 3, 2009
Condition(s): Non-small Cell Lung Cancer
10
Completed
Study of Anti-Epidermal Growth Factor Receptor (EGFr) Antibody, Cetuximab, in Combination With Gemcitabine/Carboplatin in Patients With Stage IV Lung Cancer
Last Updated: June 25, 2010
Condition(s): Stage IV Non-small Cell Lung Cancer
11
Active, not recruiting
Erlotinib Versus Gemcitabine/Carboplatin in Chemo-naive Stage IIIB/IV Non-Small Cell Lung Cancer Patients With Epidermal Growth Factor Receptor (EGFR) Exon 19 or 21 Mutation
Last Updated: May 18, 2011
Condition(s): Non-small Cell Lung Cancer
12
Recruiting
Study of Erlotinib (Tarceva®) in Combination With OSI-906 in Patients With Advanced Non-small Cell Lung Cancer (NSCLC) With Activating Mutations of the Epidermal Growth Factor Receptor (EGFR) Gene
Last Updated: May 16, 2012
Condition(s): Non Small Cell Lung Cancer; NSCLC
13
Active, not recruiting
A Non-interventional Survey on the EGFR (Epidermal Growth Factor Receptor) Mutation Status in Completely Resected Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Adenocarcinoma Histology
Last Updated: May 14, 2012
Condition(s): Non-Small Cell Lung Cancer
14
Recruiting
Sorafenib Treatment in Non-Small Cell Lung Cancer After Failure of Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitor
Last Updated: June 16, 2009
Condition(s): Non-Small Cell Lung Cancer
15
Recruiting
A Trial of Gefitinib in Combination With BKM120 in Patients With Advanced Non-Small Cell Lung Cancer, With Enrichment for Patients Whose Tumours Harbour Molecular Alterations of PI3K Pathway and Known to Overexpress EGFR
Last Updated: April 3, 2012
Condition(s): Non-Small Cell Lung Cancer; Solid Tumors
16
Completed
To Study the Changes in Protein in Lung Cells of Asian Patients With Advanced Non-small Cell Lung Cancer (NSCLC)
Last Updated: August 5, 2011
Condition(s): Non Small Cell Lung Cancer
17
Active, not recruiting
A Study of Tarceva After Surgery With or Without Adjuvant Chemotherapy in Non-Small Cell Lung Carcinoma (NSCLC) Patients Who Have Epidermal Growth Factor Receptor (EGFR) Positive Tumors
Last Updated: March 9, 2012
Condition(s): Non-small Cell Lung Cancer
18
Recruiting
A Study to Assess the Incidence of EGFR Mutation in Patients With Newly Diagnosed Locally Advanced or Metastatic Non-Small Cell Lung Cancer in the UK, And of Tarceva (Erlotinib) as First-Line Therapy in EGFR Mutation Positive Patients.
Last Updated: May 21, 2012
Condition(s): Non-Small Cell Lung Cancer
19
Recruiting
Study of Pemetrexed Versus Gefitinib in Patients With Locally Advanced or Metastatic Non Small Cell Lung Cancer Who Have Previously Received Platinum-Based Chemotherapy Without Epidermal Growth Factor Receptor (EGFR) Mutations
Last Updated: May 14, 2012
Condition(s): Non Small Cell Lung Cancer
20
Recruiting
Radiotherapy Combined With Iressa for EGFR Mutation Positive Patients With Locally Advanced Non-small Cell Lung Cancer (NSCLC)
Last Updated: August 1, 2011
Condition(s): Non-small Cell Lung Cancer

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=EGFR+Non-small+cell+lung+cancer

Page 1 of Clinical Trials for EGFR Non-small cell lung cancer, 286 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About